Blog
4 Relative Price Strength Picks for Today's Stock Market
The U.S. stock market seems to be heading in a positive direction, but it's likely to be a bumpy ride. The Federal Reserve's decision to leave interest rates as they are suggests that inflation is
Avnet's Q3 Earnings Beat Estimates on Record Components Sales
Avnet, Inc. AVT reported better-than-expected third-quarter fiscal 2026 results. The company’s third-quarter adjusted earnings of $1.48 per share beat the Zacks Consensus Estimate by 11.28%. The
Woodward's Q2 Earnings & Revenues Beat Estimates, Increase Y/Y
Woodward, Inc. WWD reported second-quarter fiscal 2026 adjusted net earnings per share (EPS) of $2.27, which jumped 34.3% year over year and beat the Zacks Consensus Estimate by 13.5%.
Quarterly net
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance
CVS Health CVS is scheduled to report first-quarter 2026 results on May 6, before the market opens.
The company posted adjusted earnings per share (EPS) of $1.09 in the last reported quarter, which
Upbound Group (UPBD) Q1 Earnings Top Estimates
Upbound Group (UPBD) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1 per share a year ago. These figures
Wayfair (W) Q1 Earnings Match Estimates
Wayfair (W) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.1 per share a year ago. These figures are adjusted for
TriNet Group (TNET) Q1 Earnings and Revenues Top Estimates
TriNet Group (TNET) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $1.99 per share a year ago. These
Sirius XM (SIRI) Beats Q1 Earnings and Revenue Estimates
Sirius XM (SIRI) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to earnings of $0.59 per share a year ago. These figures
T. Rowe Price (TROW) Beats Q1 Earnings Estimates
T. Rowe Price (TROW) came out with quarterly earnings of $2.52 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.23 per share a year ago. These
SunCoke Energy (SXC) Reports Q1 Loss, Beats Revenue Estimates
SunCoke Energy (SXC) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of $0.08. This compares to earnings of $0.2 per share a year ago. These figures are
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates
Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $1.07 per share a year ago
Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates
Cartesian Therapeutics, Inc. (RNAC) came out with a quarterly loss of $1.46 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to a loss of $0.68 per share a year ago
ProPetro Holding (PUMP) Reports Q1 Loss, Tops Revenue Estimates
ProPetro Holding (PUMP) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.09 per share a year ago. These
Option Care (OPCH) Q1 Earnings Beat Estimates
Option Care (OPCH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.4 per share a year ago. These figures
Blue Owl Capital Inc. (OWL) Q1 Earnings Match Estimates
Blue Owl Capital Inc. (OWL) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.17 per share a year ago. These figures
OneWater Marine (ONEW) Reports Q2 Loss, Misses Revenue Estimates
OneWater Marine (ONEW) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.13 per share a year ago. These figures are
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates
NovoCure (NVCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.31 per share a year ago. These figures are
Martin Marietta (MLM) Q1 Earnings and Revenues Beat Estimates
Martin Marietta (MLM) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.9 per share a year ago. These
Altria (MO) Q1 Earnings and Revenues Surpass Estimates
Altria (MO) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.23 per share a year ago. These figures are
LKQ (LKQ) Q1 Earnings Meet Estimates
LKQ (LKQ) came out with quarterly earnings of $0.67 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.79 per share a year ago. These figures are adjusted for
L3Harris (LHX) Q1 Earnings and Revenues Top Estimates
L3Harris (LHX) came out with quarterly earnings of $2.72 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $2.41 per share a year ago. These figures
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates
Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to a loss of $0.82 per share a year ago
Hippo Holdings Inc. (HIPO) Q1 Earnings Top Estimates
Hippo Holdings Inc. (HIPO) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to a loss of $1.91 per share a year ago. These
Kirby (KEX) Beats Q1 Earnings and Revenue Estimates
Kirby (KEX) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.41 per share. This compares to earnings of $1.33 per share a year ago. These figures are
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
Indivior Pharmaceuticals Inc. (INDV) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.41 per share a year


